Nitinotes is a privately-held medical device company based in caesarea Israel. Its flagship product is the endozip™, a novel robotic gastroscopic solution for safer, simpler GI suturing. Backed by clinical success and prominent KOLs, Nitinotes’ endozip proceedure provides an effective, minimally-invasive solution to class 1 and 2 obesity patients, for the majority of whom gold-standard bariatric surgery is uncovered and/or inadvisable.
Location: Israel, Haifa District, Caesarea
Employees: 1-10
Total raised: $7.1M
Founded date: 2014
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.05.2020 | - | $7.1M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 10.05.2020 | Nitinotes announces closing of an internal $7.1M series A1 f... | Bringing the total funds raised by Nitinotes to $11.5M, this funding will go towards finalizing the ... | elron.com/... |